Acne fulminans: explosive systemic form of acne, J Eur Acad Dermatol Venereol, vol.25, issue.5, pp.501-507, 2011. ,
European S1 guideline for the treatment of hidradenitis suppurativa/ acne inversa, J Eur Acad Dermatol Venereol, vol.29, issue.4, pp.619-644, 2015. ,
Bacterial pathogens are associated with Hidradenitis suppurativa, Emerg Infect Dis, vol.20, issue.12, pp.1990-1998, 2014. ,
Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa, Dermatology, vol.222, issue.1, pp.49-58, 2011. ,
Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients, J Antimicrob Chemother, vol.71, issue.2, pp.513-520, 2016. ,
The microbiological landscape of anaerobic infections in Hidradenitis Suppurativa: a prospective metagenomic study, Clin Infect Dis, vol.65, issue.2, pp.282-291, 2017. ,
Immunomodulating effects of antibiotics: literature review, Infection, vol.24, pp.275-291, 1996. ,
A case of acne fulminans presenting with systemic symptoms resembling acute appendicitis with maculopapular purpura-like eruption exacerbated by systemic steroids, Dermatol Ther, vol.26, issue.4, pp.367-369, 2013. ,
The treatment of acne fulminans: a review of 25 cases, Br J Dermatol, vol.141, issue.2, pp.307-309, 1999. ,
Acne flare on isotretinoin: a pointer to diagnosis of hidradenitis suppurativa, Ann Dermatol Venereol, vol.146, issue.1, pp.4-8, 2019. ,
French Society of Dermatology and Club Rheumatisms and Inflammation. Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases, J Am Acad Dermatol, vol.74, issue.6, pp.1153-1159, 2016. ,